Literature DB >> 9761361

Ammonia clearance by peritoneal dialysis and continuous arteriovenous hemodiafiltration.

K Y Wong1, S N Wong, S Y Lam, S Tam, N S Tsoi.   

Abstract

We report the use of continuous arteriovenous hemodiafiltration (CAVHD) in a neonate with severe hyperammonemia due to a urea cycle disorder. We compared the ammonia clearance (C(NH3)) for peritoneal dialysis (PD) and CAVHD. C(NH3) for CAVHD was 7.45 ml/min per m2 at a dialysate flow of 300 ml/h and was 10.55 ml/min per m2 at a dialysate flow rate of 600 ml/h. The mean PD clearance was 2.15 ml/min per m2. Our data suggest that CAVHD is superior to PD for the removal of plasma ammonia. We conclude that CAVHD should be considered a reasonable alternative in the treatment of neonatal hyperammonemia in urea cycle disorders when medical treatment fails.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9761361     DOI: 10.1007/s004670050511

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  15 in total

Review 1.  Ornithine carbamoyltransferase deficiency.

Authors:  J E Wraith
Journal:  Arch Dis Child       Date:  2001-01       Impact factor: 3.791

Review 2.  Detection of inborn errors of metabolism in the newborn.

Authors:  A Chakrapani; M A Cleary; J E Wraith
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-05       Impact factor: 5.747

3.  Efficacy and safety of intermittent hemodialysis in infants and young children with inborn errors of metabolism.

Authors:  I-Jung Tsai; Wuh-Liang Hwu; Shu-Chien Huang; Ni-Chung Lee; En-Ting Wu; Yin-Hsiu Chien; Yong-Kwei Tsau
Journal:  Pediatr Nephrol       Date:  2013-09-08       Impact factor: 3.714

4.  Short-term survival of hyperammonemic neonates treated with dialysis.

Authors:  Stefano Picca; Carlo Dionisi-Vici; Andrea Bartuli; Tommaso De Palo; Francesco Papadia; Giovanni Montini; Marco Materassi; Maria Alice Donati; Enrico Verrina; Maria Cristina Schiaffino; Carmine Pecoraro; Emilia Iaccarino; Enrico Vidal; Alberto Burlina; Francesco Emma
Journal:  Pediatr Nephrol       Date:  2014-09-04       Impact factor: 3.714

5.  Acute treatment of hyperammonemia by continuous renal replacement therapy in a newborn patient with ornithine transcarbamylase deficiency.

Authors:  Hyo Jeong Kim; Se Jin Park; Kook In Park; Jin Sung Lee; Ho Sun Eun; Ji Hong Kim; Jae Il Shin
Journal:  Korean J Pediatr       Date:  2011-10-31

Review 6.  Hyperammonemia in review: pathophysiology, diagnosis, and treatment.

Authors:  Ari Auron; Patrick D Brophy
Journal:  Pediatr Nephrol       Date:  2011-03-23       Impact factor: 3.714

Review 7.  The Role of RRT in Hyperammonemic Patients.

Authors:  Shruti Gupta; Andrew Z Fenves; Robert Hootkins
Journal:  Clin J Am Soc Nephrol       Date:  2016-05-19       Impact factor: 8.237

8.  A technique for rapid exchange of continuous renal replacement therapy.

Authors:  Peter Yorgin; Marlys Ludlow; Annabelle Chua; Steve Alexander
Journal:  Pediatr Nephrol       Date:  2006-03-14       Impact factor: 3.714

9.  High-dose continuous renal replacement therapy for neonatal hyperammonemia.

Authors:  Joann M Spinale; Benjamin L Laskin; Neal Sondheimer; Sarah J Swartz; Stuart L Goldstein
Journal:  Pediatr Nephrol       Date:  2013-03-08       Impact factor: 3.714

10.  Peritoneal dialysis in neonates with inborn errors of metabolism: is it really out of date?

Authors:  Ivana Pela; Daniela Seracini; Maria Alice Donati; Giancarlo Lavoratti; Elisabetta Pasquini; Marco Materassi
Journal:  Pediatr Nephrol       Date:  2007-09-26       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.